PARK CITY, Utah–(BUSINESS WIRE)–BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System for urge urinary incontinence (UUI), announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a favorable payment adjustment for the 2025 Medicare Hospital Outpatient Prospective Payment and Ambulatory…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
LOGAN, Utah, June 1, 2022 /PRNewswire/ — Micronutrient deficiencies disproportionately affect women and children in low- and middle-income countries. Such deficiencies can lead to systemic and enduring morbidities in individuals and their children, and if […]
Company recognized for its CellSentials supplement, Celavive skincare line, research and development, and USANA Foundation SALT LAKE CITY, June 12, 2025 /PRNewswire/ — USANA, a leader in global nutrition, was recently honored by the Best […]
SALT LAKE CITY, April 10, 2025 /PRNewswire/ — Huntsman Cancer Institute at the University of Utah (the U) broke ground on its second Comprehensive Cancer Center on Tuesday, April 8, advancing construction of a new […]
Copyright © 2026 Biotech Networks
